REQUEST A DEMO
Total
USD $0.00
Search more companies

Au Galen Pharm (Serbia)

Main Activities: Department Stores
Full name: Au Galen Pharm Profile Updated: September 30, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Au Galen Pharm is part of the Galen Pharm pharmacy chain in Serbia. The company operates retail pharmacies offering prescription medicines, OTC products, dermocosmetics, dietary supplements, medical devices and health care items. Business segments include pharmaceutical retail, patient counseling, loyalty programs and online sales through the Galen Pharm digital platform. Key assets include the pharmacy network, distribution partnerships and brand recognition. Strategically, the company aims to expand accessibility to pharmaceutical services and strengthen its market position through professional service and diversified health product offerings.

Headquarters
Beogradska 8
Belgrade; Belgrade;

Contact Details: Purchase the Au Galen Pharm report to view the information.

Website: http://www.galenpharm.com

Basic Information
Total Employees:
Purchase the Au Galen Pharm report to view the information.
Registered Capital:
Purchase the Au Galen Pharm report to view the information.
Financial Auditors:
Purchase the Au Galen Pharm report to view the information.
Incorporation Date:
January 29, 2007
Key Executives
Purchase this report to view the information.
Director
Ownership Details
Purchase this report to view the information.
100%
Subsidiaries
Apotekarska Ustanova Elixa
33.33%
Company Performance
Financial values in the chart are available after Au Galen Pharm report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency RSD. Absolute financial data is included in the purchased report.
Net sales revenue
9.03%
Total operating revenue
8.95%
Operating profit (EBIT)
265.45%
EBITDA
203.08%
Net Profit (Loss) for the Period
-45.32%
Total Assets
47.38%
Total Equity
2.91%
Operating Profit Margin (ROS)
1.02%
Net Profit Margin
-0.19%
Return on Equity (ROE)
-2.54%
Debt/Equity
224.27%
Quick Ratio
-0.03%
Cash Ratio
-0.03%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?